The use of terlipressin during living donor liver transplantation: Effects on systemic and splanchnic hemodynamics and renal function

Critical Care Medicine

Volumn 39, Issue 6, 2011, Pages 1329-1334

  Mukhtar, Ahmed ^a   Salah, Maged ^a   Aboulfetouh, Fawzia ^a   Obayah, Gihan ^a   Samy, Maha ^b   Hassanien, Azza ^b   Bahaa, Mohamed ^c   Abdelaal, Amr ^c   Fathy, Mohamed ^c   Saeed, Hany ^c   Rady, Mohamed ^c   Mostafa, Ibrahim ^b   El Meteini, Mahmoud ^c  

^a CAIRO UNIVERSITY   (Egypt)

^b THEODOR BILHARZ RESEARCH INSTITUTE   (Egypt)

^c AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

liver transplantation; renal function; terlipressin

Indexed keywords

CREATININE; CYSTATIN C; LACTIC ACID; SODIUM CHLORIDE; TERLIPRESSIN;

ADULT; ALKALOSIS; ANESTHESIA INDUCTION; ARTICLE; BLOOD GAS ANALYSIS; BOLUS INJECTION; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG INFUSION; ELECTIVE SURGERY; FEMALE; GAS EXCHANGE; HEART INDEX; HEART RATE; HEMODYNAMICS; HEPATIC ARTERY LIGATION; HEPATIC VEIN; HUMAN; KIDNEY FUNCTION; LACTATE BLOOD LEVEL; LIVER TRANSPLANTATION; LIVING DONOR; MALE; MEAN ARTERIAL PRESSURE; PEROPERATIVE CARE; PORTAL VEIN; PORTAL VEIN BLOOD PRESSURE; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIAL ARTERY; RANDOMIZED CONTROLLED TRIAL; SPLANCHNIC BLOOD FLOW; SYSTEMIC CIRCULATION; SYSTEMIC VASCULAR RESISTANCE; TISSUE OXYGENATION;

EID: 79957631929     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3182120842     Document Type: Article

References (20)

1. Cormdirae EJ, Lindor MJ, Faram JV, et al: Anesthesia for hepatic transplantation, cardiovascular and metabolic alterations and their management. Anesth Analg 1985; 64: 108-116.
2. Kiszka-Kanowitz M, Henriksen JH, Moller S, et al: Blood volume distribution in patients with cirrhosis: Aspects of the dual-head gamma- camera technique. J Hepatol 2001; 35: 605-612. (Pubitemid 33078270)
3. Roth JV: The use of vasopressin bolus to treat refractory hypotension secondary to reperfusion during orthotopic liver transplantation. Anesth Analg 2006; 103:261. (Pubitemid 44036087)
4. Wagener G, Gubitosa G, Renz J, et al: Vasopressin decreases portal vein pressure and flow in the native liver during liver transplantation Liver Transpl 2008; 14:1664-1670.
5. O'Brien A, Clapp L, Singer M: Terlipressin for norepinephrine-resistant septic shock. Lancet 2002; 359:1209-1210. (Pubitemid 34304264)
6. Baik SK, Jeong PH, Ji SW, et al: Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: A randomized comparison. Am J Gastroenterol 2005; 100:631-635. (Pubitemid 40487563)
7. Narahara Y, Kanazawa H, Taki Y, et al: Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis. Gastroenterol Hepatol 2009; 24:1791-1797.
8. Mukhtar A, Aboulfetouh F, Obayah G, et al: The safety of modern hydroxyethyl starch in living donor liver transplantation: A comparison with human albumin. Anesth Analg 2009; 109:924-930.
9. Murphy ND, Kodakat SK, Wendon JA, et al: Liver and intestinal lactate metabolism in patients with acute hepatic failure undergoing liver transplantation. Crit Care Med 2001; 29:2111-2118. (Pubitemid 33063538)
10. Finney H, Newman DJ, Gruber W, et al: Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin Chem 1997; 43:1016-1022. (Pubitemid 27246994)
11. Biancofiore G, Pucci L, Cerutti E, et al: Cystatin C as a marker of renal function immediately after liver transplantation. Liver Transpl 2006; 12:285-291. (Pubitemid 43273789)
12. Uriz J, Gines P, Cardenas A, et al: Terlipressin plus albumin infusion: An effective and safe therapy of hepatorenal syndrome. J Hepatol 2000; 33:43-48. (Pubitemid 30418933)
13. Møller S, Henriksen JH: Cardiovascular complications of cirrhosis. Gut 2008; 57:268-278. (Pubitemid 351158057)
14. Kam PC, Williams S, Yoong FF: Vasopressin and terlipressin: Pharmacology and its clinical relevance. Anaesthesia 2004; 59:993-1001. (Pubitemid 39307237)
15. Schrier RW: Decreased effective blood volume in edematous disorders: What does this mean? J Am Soc Nephrol 2007; 18:2028-2031. (Pubitemid 47041067)
16. Gainza FJ, Valdivieso A, Quintanilla N, et al: Evaluation of acute renal failure in the liver transplantation perioperative period: Incidence and impact. Transplant Proc 2002; 34:250-251. (Pubitemid 34311653)
17. Mutlu GM, Factor P: Role of vasopressin in the management of septic shock. Intensive Care Med 2004; 30:1276-1291. (Pubitemid 38951709)
18. Ioannou G, Doust J, Rockey DC: Terlipressin for acute esophageal variceal hemorrhage. Cochrane Database Syst Rev 2001; 1:CD002147.
19. Moller S, Hansen EF, Becker U, et al: Central and systemic hemodynamic effects of terlipressin in portal hypertensive patients. Liver 2000; 20:51-59. (Pubitemid 30095288)
20. Gondolesi GE, Florman S, Matsumoto C, et al: Venous hemodynamics in living donor right lobe liver transplantation. Liver Transpl 2002; 8:809-813 (Pubitemid 35012292)